| Browse by: | Sort by: |
Aggressive Pituitary Tumors and Carcinomas: Two Sides of the Same Coin?
Jacqueline Trouillas, MD, PhD
University of Lyon, Lyon, France
Available
Treatment of Aggressive Pituitary Tumors and Carcinomas
Ann I McCormack, MD, PhD
St. Vincent's Hospital, Sydney, Australia
Coming soon
Molecular Underpinnings of the Aggressive Pituitary Tumor
Gerald Raverot, MD, PhD
Hospices Civils de Lyon, Lyon Cedex 03, France
Available
President's Announcements and Awards
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Available
Outstanding Innovation Award Presented to John Kopchick, PhD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Available
New Pathways in Cellular and Systemic Lipid Metabolism
Peter J Tontonoz, MD, PhD
University of California, Los Angeles, Los Angeles, CA
Available
Nuclear Receptor Signaling in Breast and Prostate Cancer
Myles A Brown, MD
Dana-Farber Cancer Institute, Boston, MA
Available
Chair
Mishaela R Rubin, MD
Columbia University, New York, NY
Available
Genetic control of Parathyroid Gland fate specification and organogenesis
Nancy R Manley, PhD
University of Georgia, Athens, GA
Available
Genetics of Parathyroid Tumors
Rajesh V Thakker, MD
University of Oxford, Oxford, United Kingdom
Available
Preoperative and Surgical Approaches to Parathyroid Gland Resection
Quan-Yang Duh, MD
San Francisco VA Medical Center, San Francisco, CA
Available
Thyroid Cancer Genetics and Implications for Therapy
Nikita Pozdeyev, MD, PhD
University of Colorado, Aurora, CO
Available
A Glimmer of Hope: Novel Combination Therapy for the Treatment of Anaplastic Thyroid Cancer
Maria E Cabanillas, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
Available
Super-Enhancer Targeting in Advanced Thyroid Cancers
Matthew D Ringel, MD
The Ohio State University, Columbus, OH
Available
Questions and Answers
Mabel M Ryder, MD
Mayo Clinic, Rochester, MN, United States
Nikita Pozdeyev, MD, PhD
University of Colorado, Aurora, CO
Maria E Cabanillas, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
Matthew D Ringel, MD
The Ohio State University, Columbus, OH
Application of New Adrenal Cancer Models to Screen Therapeutics
Katja Kiseljak-Vassiliades, DO
University of Colorado, Denver, Aurora, CO
Available
New In Vitro Models for Studying Human Adreno-Cortical Cancer (ACC)
Leo J Hofland, PHD
Erasmus Medical Center, Rotterdam, Netherlands
Available
Mouse Models of Adrenal Tumors
Pierre Val, PhD
National Center for Scientific Research, Clermont-Ferrand, France
Available
Circulating Biomarkers and Prognosis in Neuroendocrine Tumors
Mark Kidd, PhD
Wren Laboratories, Branford, CT
Available
Peptide Receptor Radiotherapy
Wouter W. de Herder, MD,PHD
Erasmus MC, Rotterdam, Netherlands
Available
New Avenues for the Treatment of Neuroendocrine Tumors
Marianne Ellen Pavel, MD
Friedrich-Alexander Univ Erlangen-Nürnberg, Erlangen, Germany
Available
Bone Disease in Breast Cancer
Catherine Van Poznak, MD
Univ of Michigan, Ann Arbor, MI
Available
Mechanisms, Monitoring and Treatment of Prostate Cancer-Related Bone Disease
Gregory A Clines, MD, PhD
Univ of Michigan, Ann Arbor, MI
Available
Bone Disease in Multiple Myeloma
Suzanne Lentzsch, MD, PhD
Columbia Univ Med Ctr, New York, NY
Available
President's Announcements and Awards
Lynnette K. Nieman, MD
President, Endocrine Society, Washington, DC
Available
